Title: Producing Recombinant Glycoproteins in the Baculovirus-Insect Cell System
1Producing Recombinant Glycoproteins in the
Baculovirus-Insect Cell System
- Donald L. Jarvis, Jason R. Hollister, Jared J.
Aumiller - Department of Molecular Biology
- University of Wyoming
- Laramie, WY, USA
2Baculovirus-Insect CellExpression System
- Binary system.
- Recombinant baculovirus vector.
- Delivers gene of interest.
- Insect cell host.
- Produces protein product.
3AdvantagesBaculovirus-Insect Cell System
- High level gene expression.
- Strong promoter from viral polh gene.
- Eucaryotic protein processing.
- Glycosylation.
Jarvis, 1997
4Protein Glycosylation
- Common covalent modification.
- Can influence protein function.
- Elaborate biochemical pathways.
- N-glycosylation.
5Mammalian N-glycosylationPathway
6Mammalian N-glycans
7Major Insect N-glycans
8Major Insect vs Mammalian N-Glycans
Marchal et al., 2001
9Glycoprotein Sialylation
- Functionally significant.
- Influences glycoprotein behavior.
- Nonsialylated gP rapidly cleared in vivo.
10Major DisadvantageBaculovirus-Insect Cell System
- Truncated N-glycosylation pathway.
- Cannot produce sialylated N-glycans.
Marchal et al., 2001
11How to Address this Problem?
- Metabolic engineering.
- Genetically modify (humanize) insect protein
N-glycosylation pathway.
12Humanizing Insect Protein Glycosylation Pathways
- Identify missing functions.
- Identify human/mammalian genes.
- Place under control of insect promoters.
- Genetically transform insect cell lines.
- Isolate transgenic insect cells that
constitutively express these genes.
Jarvis et al., 1998 Jarvis et al., 2003, Jarvis,
2003
13Major Insect vs Mammalian N-Glycans
14Immediate Early Expression Plasmids
15A Dual Immediate Early Expression Plasmid
16Creating Transgenic Insect Cell Lines
- Constructed pIE1ß4GalT, pIE1ST6, pIE1Neo.
- Cotransfected Sf9 or High Five cells.
- Isolated drug-resistant clones.
- Screened for glycosyltransferase expression.
17Transgenic Insect Cell Lines
- Normal morphologies.
- Normal growth properties.
- Support baculovirus infection.
- Support baculovirus gene expression.
- Constitutive Gal-T and Sial-T activities.
- Can they produce humanized glycoproteins?
Breitbach and Jarvis, 2001 Hollister et al.,
1998 Hollister and Jarvis 2001
18gp64 Lectin Blots
No competing sugars
1-Sf9 2-Sfß4GalT 3-Sfß4GalT/ST6
Competing sugars
Hollister and Jarvis, 2001
19HPAEC-PAD Results
M3F
Sf9
M3
Sfß4GalT
GalGlcNAcM3F
Sfß4GalT/ST6
SialylGalGlcNAcM3F
Hollister et al., 2002
20MALDI-TOF Results
1079
Sf9
933
1445
Relative Abundance
Sfß4GalT
1079
1079
1445
Sfß4GalT/ST6
1758
1736
1283
1607
Hollister et al., 2002
21Conclusions
- Transgenic insect cell lines produced partially
humanized N-glycans. - Galactosylated and sialylated.
- But, they were monoantennary.
- Only a3 branch was elongated.
22Next Question
- Can insect cells be further humanized to produce
BIantennary, sialylated N-glycans?
23Major Insect vs Mammalian N-Glycans
24A New Transgenic Cell Line SfSWT-1
- ß1,4-galactosyltransferase.
- a2,6-sialyltransferase.
- N-acetylglucosaminyltransferase II.
- N-acetylglucosaminyltransferase I.
- a2,3-sialyltransferase.
Hollister et al., 2002
25SfSWT-1 Cells
- Normal morphology and growth.
- Support baculovirus infection.
- Support baculovirus gene expression.
- Express all five transferase genes.
- Can they produce biantennary N-glycans?
Hollister et al., 2002
26HPAEC-PAD Results
M3F
Sf9
M3
Sfß4GalT
GalGlcNAcM3F
Sfß4GalT/ST6
SialylGalGlcNAcM3F
SfSWT-1
GalGlcNAc2M3F
SialylGalGlcNAc2M3F
Hollister et al., 2002
27MALDI-TOF Results
Sf9
Sfß4GalT
Sfß4GalT/ST6
SfSWT-1
Hollister et al., 2002
28ESI-MS/MS Results
SfSWT-1
1810
2123
1648
1283
1664
1445
1607
Hollister et al., 2002
29ESI-MS/MS Results
SfSWT-1
1810
2123
1648
1283
1664
1445
1607
Hollister et al., 2002
30Conclusions 2
- Sf9 cells were engineered to produce biantennary,
monosialylated N-glycans. - Commercially available.
- MIMIC (Invitrogen).
31Requirements for gP sialylation
- Sialyltransferase.
- Acceptor substrate (terminally galactosylated).
- Donor substrate (CMP-sialic acid).
- CMP-sialic acid transporter.
32New Questions
- Where does the donor CMP-SA come from?
- How is it transported into the Golgi?
33Effects of FBS on Glycosylation by Transgenic
Insect Cell Lines
FCS
NO FCS
(Sfß4GalT/ST6)
Hollister et al., 2003
34FBS Factor is a Sialoglycoprotein
Hollister et al., 2003
35Conclusions 3
- Sfß4GalT/ST6 and SfSWT-1 cells require FBS or
serum sialoglycoproteins for de novo glycoprotein
sialylation. - These cells can salvage sialic acids from
extracellular serum sialoglycoproteins.
Hollister et al., 2003
36Final Question
- Can we create a transgenic insect cell line that
produces humanized recombinant glycoproteins when
cultured in SFM?
37Newest Transgenic Cell Line SfSWT-3
- ß1,4-galactosyltransferase.
- a2,6-sialyltransferase.
- N-acetylglucosaminyltransferase II.
- N-acetylglucosaminyltransferase I.
- a2,3-sialyltransferase.
- Sialic acid synthase.
- CMP-sialic acid synthetase
Aumiller et al., 2003
38SfSWT-3 Cells
- Normal morphology and growth.
- Support baculovirus infection.
- Support baculovirus gene expression.
- Express all seven mammalian genes.
- Can they produce biantennary, sialylated
N-glycans in the absence of serum?
Aumiller et al., 2003
39Lectin Blotting Results
Antibody
Sial-specific lectin
Lectin competing sugar
Aumiller et al., 2003
40HPAEC-PAD Results
SfSWT-3 SFM
SfSWT-3 SFM/ManNAc
SfSWT-3 SFM/ManNAc Neuraminidase control
Aumiller et al., 2003
41Overall Summary
- Genetic engineering can be used to extend insect
cell protein glycosylation pathways. - New baculovirus-insect cell systems can produce
structurally authentic glycoproteins. - Products appear to be quite homogeneous.
- Amenable to crystallization and structural
analysis.
42Acknowledgements
- Jason Hollister
- Eric Finn
- Carla Weinkauf
- Neung-Seon Seo
- Jared Aumiller
- Dale Howe
- Kevin Breitbach
- NIH GM49734
- Harald Conradt
- Eckard Grabenhorst
- Manfred Nimtz
- Joel Shaper
- Jim Paulson
- Harry Schachter
- Pamela Stanley
- Shuichi Tsuji